Fu Shan - 18 Mar 2026 Form 3 Insider Report for SINOVAC BIOTECH LTD (SVA)

Reporting relationship: Director
Issuer ticker: SVA
Reported as of: 18 Mar 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 18 Mar 2026, 08:11:43 UTC
Source filing: View source filing
Reporting owner signature: /s/ Jia Zhao, Attorney-in-Fact

Key filing fact

Fu Shan filed Form 3 for SINOVAC BIOTECH LTD (SVA) on 18 Mar 2026.

Key facts

This page summarizes Fu Shan's Form 3 filing for SINOVAC BIOTECH LTD (SVA).
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 18 Mar 2026, 08:11.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002114111 Primary reporting owner

FU SHAN

Relationship: Director
Address: SEE REMARKS, BEIJING, CHINA
Signature: /s/ Jia Zhao, Attorney-in-Fact
Signature date: 18 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SVA holding

Common shares, par value $0.001 per share

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 5,903,000
Date: 18 Mar 2026
Ownership: By Vivo Capital Fund VIII, L.P., Vivo Capital Surplus Fund VIII, L.P. and Vivo Capital Fund IX, L.P.
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The Reporting Person is a managing member of Vivo Capital VIII, LLC, which is the general partner of Vivo Capital Fund VIII, L.P. and Vivo Capital Surplus Fund VIII, L.P. The Reporting Person may be deemed to share voting and dispositive power over 1,196,073 common shares, par value $0.001 per share, of the Issuer (the "Common Shares") held by Vivo Capital Fund VIII, L.P. and 165,163 Common Shares held by Vivo Capital Surplus Fund VIII, L.P. with three other voting members. The Reporting Person, as the managing member of Vivo Capital IX, LLC, which is the general partner of Vivo Capital Fund IX, L.P., may be deemed to share voting and dispositive power over 4,541,764 Common Shares held by Vivo Capital Fund IX, L.P. with five other voting members.

Footnote F2

The Reporting Person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

SEC remarks

The full street address is Unit 1501-1505, North Tower, CP Center, 20 Jinhe East Road, Chaoyang District. Exhibit 24 - Power of Attorney